Table 6.
Variables | Lp (a) (mg/dL) |
Apo B (mg/dL) |
Leptin (ng/mL) |
TNF α (pg/mL) |
IL−1β (pg/mL) |
IL−10 (pg/mL) |
IL−6 (pg/mL) |
ET−1 (pg/mL) |
AN (μg/mL) |
|
---|---|---|---|---|---|---|---|---|---|---|
VO2 peak (mL) | r | 0.074 | 0.302 | −0.479 * | 0.045 | −0.426 | 0.175 | −0.320 | −0.355 | 0.011 |
p value | 0.708 | 0.126 | 0.010 * | 0.818 | 0.100 | 0.501 | 0.196 | 0.075 | 0.955 | |
VO2 pro kg | r | 0.278 | 0.187 | −0.761 * | −0.126 | −0.379 | −0.011 | −0.477 * | −0.164 | 0.205 |
p value | 0.152 | 0.351 | 0.001 * | 0.522 | 0.147 | 0.968 | 0.045 * | 0.422 | 0.295 | |
VO2% | r | 0.231 | 0.195 | −0.727 * | −0.122 | −0.414 | −0.059 | −0.456 | −0.161 | 0.1 |
p value | 0.237 | 0.330 | 0.001 * | 0.537 | 0.111 | 0.822 | 0.057 | 0.432 | 0.36 | |
VO2@AT | r | −0.107 | 0.365− | −0.434 * | −0.180 | −0.412 | 0.313 | −0.030 | −0.262 | −0.091 |
p value | 0.618 | 0.087 | 0.034 * | 0.401 | 0.184 | 0.256 | 0.915 | 0.228 | 0.471 | |
OUES | r | 0.047 | 0.288 | −0.361 | 0.121 | −0.363 | 0.143 | −0.115 | −0.256 | 0.266 |
p value | 0.811 | 0.145 | 0.059 | 0.540 | 0.167 | 0.583 | 0.649 | 0.207 | 0.171 | |
OUES% | r | 0.117 | 0.219 | −0.575 * | −0.087 | −0.357 | 0.028 | −0.411 | −0.425 * | 0.074 |
p value | 0.553 | 0.272 | 0.001 * | 0.659 | 0.174 | 0.915 | 0.090 | 0.014 * | 0.71 | |
VO2/HR | r | −0.000 | 0.270 | −0.407 * | 0.091 | −0.379 | 0.093 | −0.275 | −0.776 * | −0.045 |
p value | 1000 | 0.174 | 0.031 * | 0.646 | 0.147 | 0.722 | 0.269 | 0.045 * | 0.809 | |
VO2/hr% | r | 0.124 | 0.176 | −0.692 * | −0.088 | −0.399 | −0.135 | −0.453 | −0.262 | 0.06 |
p value | 0.529 | 0.380 | 0.001 * | 0.657 | 0.126 | 0.605 | 0.059 | 0.197 | 0.726 | |
dVO2/WR slope | r | −0.061 | 0.022 | −0.199 | −0.031 | 0.117 | 0.325 | 0.085 | −0.02 | 0.175 |
p value | 0.757 | 0.913 | 0.310 | 0.876 | 0.665 | 0.203 | 0.738 | 0.994 | 0.37 | |
VE/VCO2 slope | r | −0.200 | −0.126 | 0.394 * | 0.219 | 0.556 * | 0.059 | 0.275 | 0.279 | −0.098 |
p value | 0.308 | 0.532 | 0.038 * | 0.263 | 0.025 * | 0.822 | 0.269 | 0.168 | 0.62 | |
BR | r | −0.377 * | 0.019 | 0.016 | −0.211 | −0.042 | −0.031 | −0.139 | 0.265 | −0.231 |
p value | 0.048 * | 0.924 | 0.938 | 0.282 | 0.879 | 0.905 | 0.583 | 0.191 | 0.236 | |
FR peak | r | 0.316 | −0.121 | 0.133 | 0.082 | −0.002 | 0.216 | 0.204 | −0.365 | 0.015 |
p value | 0.101 | 0.549 | 0.501 | 0.677 | 0.993 | 0.405 | 0.417 | 0.066 | 0.934 | |
VE peak | r | 0.187 | 0.246 | −0.189 | 0.203 | 0.021 | 0.254 | 0.029 | −0.095 | 0.597 |
p value | 0.342 | 0.215 | 0.336 | 0.300 | 0.938 | 0.325 | 0.910 | 0.644 | 0.288 | |
PCP | r | 0.036 | 0.259 | −0.425 * | 0.065 | −0.445 | 0.103 | −0.317 | −0.397 * | 0.635 |
p value | 0.854 | 0.192 | 0.024 * | 0.741 | 0.084 | 0.694 | 0.200 | 0.045 * | 0.25 |
The Pearson correlation coefficient (r) was used to study the relationship between variables. * p value < 0.05. AN: adiponectin; Apo: apolipoprotein; AT: anaerobic threshold; BR: breathing reserve; ET: endothelin; FR: frequency rate; HR: hearth rate; IL: interleukin; Lp: lipoprotein; OUES: oxygen uptake efficiency slope; PCP: peak circulatory power; TNF: tumor necrosis factor; VE: ventilation rate; VE/VCO2: minute ventilation/carbon dioxide production; VO2: pulmonary oxygen uptake; WR: work rate.